Scancell Holdings Plc (SCNLF)
0.3349
+0.01
(+3.39%)
USD |
OTCM |
Jun 01, 16:00
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 347.52M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 97.21% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 62.49 |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 99.64% |
Profile
| Scancell Holdings Plc is a clinical stage biotechnology company, which develops targeted off-the-shelf active immunotherapies. Its vaccine platform includes Moditope and ImmunoBody. The company was founded by Lindy Gillian Durrant in 1996 and is headquartered in Oxford, the United Kingdom. |
| URL | http://www.scancell.co.uk |
| Investor Relations URL | https://www.scancell.co.uk/investors |
| HQ State/Province | Oxfordshire |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Scancell Holdings Plc is a clinical stage biotechnology company, which develops targeted off-the-shelf active immunotherapies. Its vaccine platform includes Moditope and ImmunoBody. The company was founded by Lindy Gillian Durrant in 1996 and is headquartered in Oxford, the United Kingdom. |
| URL | http://www.scancell.co.uk |
| Investor Relations URL | https://www.scancell.co.uk/investors |
| HQ State/Province | Oxfordshire |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
